Barclays PLC Grows Stock Position in Teleflex Incorporated (NYSE:TFX)

Barclays PLC raised its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 1.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 89,907 shares of the medical technology company’s stock after acquiring an additional 1,426 shares during the quarter. Barclays PLC owned approximately 0.19% of Teleflex worth $22,233,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Cromwell Holdings LLC grew its position in shares of Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after purchasing an additional 49 shares during the last quarter. Avior Wealth Management LLC lifted its stake in Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after buying an additional 101 shares in the last quarter. Ashton Thomas Securities LLC acquired a new stake in Teleflex during the 3rd quarter valued at $40,000. True Wealth Design LLC raised its holdings in shares of Teleflex by 16,600.0% in the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after acquiring an additional 166 shares during the last quarter. Finally, Canada Pension Plan Investment Board purchased a new stake in shares of Teleflex in the second quarter valued at $42,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Trading Down 1.7 %

Shares of TFX opened at $180.14 on Friday. Teleflex Incorporated has a twelve month low of $179.82 and a twelve month high of $257.85. The firm has a market capitalization of $8.37 billion, a P/E ratio of 35.81, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock’s fifty day simple moving average is $208.28 and its 200 day simple moving average is $220.60.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $764.40 million for the quarter, compared to the consensus estimate of $768.68 million. During the same period last year, the business posted $3.64 EPS. The company’s quarterly revenue was up 2.4% compared to the same quarter last year. On average, equities research analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be paid a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 annualized dividend and a yield of 0.75%. Teleflex’s dividend payout ratio is currently 27.04%.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Friday, November 1st. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Mizuho reduced their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. Truist Financial reaffirmed a “hold” rating and issued a $227.00 target price (down from $255.00) on shares of Teleflex in a research note on Monday, November 4th. Finally, Royal Bank of Canada lowered their price objective on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $259.00.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.